NCT02577003 Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843) Status COMPLETED Phase PHASE3
NCT02564211 Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849) Status COMPLETED Phase PHASE3
NCT02563834 A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism Status COMPLETED Phase NA
NCT02562326 A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02561130 Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga Status COMPLETED Phase PHASE4
NCT02561078 An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02554877 A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin Status COMPLETED Phase PHASE2
NCT02551874 A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin Status COMPLETED Phase PHASE3
NCT02551315 Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes Status COMPLETED Phase N/A
NCT02549924 Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE2
NCT02548741 Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes Status UNKNOWN Phase NA
NCT02548585 A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1/PHASE2
NCT02545842 Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) Status COMPLETED Phase PHASE4
NCT02540486 Long Acting Insulin Glargine Titration Web Tool (LTHome) vs Enhanced Usual Therapy of Glargine Titration Status COMPLETED Phase NA
NCT02537470 Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes Status COMPLETED Phase PHASE2